Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Epicore Bionetworks Inc. V.EBN

Industrials Pollution & Treatment Controls
"Epicore Bionetworks Inc develops, manufactures and markets biotechnology products based on natural microbes and enzymes for the aquaculture, agriculture and municipal industries."


TSXV:EBN - Post by User

Epicore Bionetworks Inc. > Q1 results disappointing
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by 2franklyon Dec 19, 2015 12:04pm
89 Views
Post# 24397909

RE:RE:RE:RE:Q1 results disappointing

RE:RE:RE:RE:Q1 results disappointingI spoke to the CEO and my understanding is they sell into those markets in USD. Plummeting Latin American currencies makes their product more expensive and perhaps prohibitive. So any relative drop in the USD might help.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities